Skip to content

Arthroscopic Guided Synovial Biopsies

Diagnosis of Temporomandibular Joint Arthritic Disease Using Arthroscopic Guided Synovial Biopsies

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03279016
Enrollment
20
Registered
2017-09-12
Start date
2018-05-31
Completion date
2019-12-31
Last updated
2018-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Temporomandibular Arthritis

Brief summary

To detect accuracy of serology in diagnosis of temporomandibular joint arthritis.

Detailed description

According to a search of previously published studies on accuracy of serology no sensitivity or specificity data was found regarding accurate detection of arthritis through serology, hence the aim of this study is to detect accuracy of serology in diagnosis of temporomandibular joint arthritis.

Interventions

None listed

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Patients suffering from TEMPOROMANDIBULAR JOINT ARTHRITIS. * Patients should be free from any systemic disease that may affect normal healing and predictable outcome. * Patients who will agree to the consent

Exclusion criteria

* Patients with any systemic disease that may affect normal healing. * Pregnant females. * Patients with acute infection. * Patients with bony ankyloses. * Patients with risk of tumor dissemination.

Design outcomes

Primary

MeasureTime frameDescription
accuracy of serology2 yearsTo determine the sensitivity or specificity of serology in diagnosis of temporomandibular joint arthritis

Secondary

MeasureTime frameDescription
C-reactive protein2 yearsTo be measured in a blood sample with (mg/dL) unit where Normal CRP levels are below 3.0 mg/dL.
Anti-Cyclic Citrullinated Peptide2 yearsTo be measured in a blood sample with (titre-AU)
ANA2 yearsTo be measured in a blood sample with binary outcome (positive or negative)
Rheumatoid factor2 yearsTo be measured in a blood sample with (IU/mL) unit as The normal reference range for RF is less than 15 IU/mL
Cellular population- type2 yearsPresence of inflammatory cells infiltrate at the synovial membrane biopsy : \- type of cells
Cellular population- number of cells2 yearsPresence of inflammatory cells infiltrate at the synovial membrane biopsy: \- mean number of cells
HLA-B272 yearsTo be measured in a blood sample with binary outcome (positive or negative)

Countries

Egypt

Contacts

Primary ContactAHMED EISSA, MASTER
drahmedadel75@gmail.com+201147700383

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026